Barbara C. Bock, Ph.D. - Publications

Affiliations: 
2000 Michigan State University, East Lansing, MI 
Area:
Molecular Biology

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Neuhaus B, Bühren S, Böck B, Alves F, Vogel WF, Kiefer F. Migration inhibition of mammary epithelial cells by Syk is blocked in the presence of DDR1 receptors. Cellular and Molecular Life Sciences : Cmls. 68: 3757-70. PMID 21499918 DOI: 10.1007/s00018-011-0676-8  0.467
2010 Böck BC, Tagscherer KE, Fassl A, Krämer A, Oehme I, Zentgraf HW, Keith M, Roth W. The PEA-15 protein regulates autophagy via activation of JNK. The Journal of Biological Chemistry. 285: 21644-54. PMID 20452983 DOI: 10.1074/Jbc.M109.096628  0.633
2008 Tagscherer KE, Fassl A, Campos B, Farhadi M, Kraemer A, Böck BC, Macher-Goeppinger S, Radlwimmer B, Wiestler OD, Herold-Mende C, Roth W. Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins. Oncogene. 27: 6646-56. PMID 18663354 DOI: 10.1038/Onc.2008.259  0.363
2007 Gdynia G, Grund K, Eckert A, Böck BC, Funke B, Macher-Goeppinger S, Sieber S, Herold-Mende C, Wiestler B, Wiestler OD, Roth W. Basal caspase activity promotes migration and invasiveness in glioblastoma cells. Molecular Cancer Research : McR. 5: 1232-40. PMID 18171980 DOI: 10.1158/1541-7786.Mcr-07-0343  0.498
2007 Eckert A, Böck BC, Tagscherer KE, Haas TL, Grund K, Sykora J, Herold-Mende C, Ehemann V, Hollstein M, Chneiweiss H, Wiestler OD, Walczak H, Roth W. The PEA-15/PED protein protects glioblastoma cells from glucose deprivation-induced apoptosis via the ERK/MAP kinase pathway. Oncogene. 27: 1155-66. PMID 17700518 DOI: 10.1038/Sj.Onc.1210732  0.493
2006 Schultze K, Böck B, Eckert A, Oevermann L, Ramacher D, Wiestler O, Roth W. Troglitazone sensitizes tumor cells to TRAIL-induced apoptosis via down-regulation of FLIP and Survivin. Apoptosis : An International Journal On Programmed Cell Death. 11: 1503-12. PMID 16820965 DOI: 10.1007/S10495-006-8896-3  0.343
2005 Du Y, Böck BC, Schachter KA, Chao M, Gallo KA. Cdc42 induces activation loop phosphorylation and membrane targeting of mixed lineage kinase 3. The Journal of Biological Chemistry. 280: 42984-93. PMID 16253996 DOI: 10.1074/Jbc.M502671200  0.583
2002 Parameswaran N, Hall CS, Bock BC, Sparks HV, Gallo KA, Spielman WS. Mixed lineage kinase 3 inhibits phorbol myristoyl acetate-induced DNA synthesis but not osteopontin expression in rat mesangial cells. Molecular and Cellular Biochemistry. 241: 37-43. PMID 12482023 DOI: 10.1023/A:1020835106255  0.7
2002 Parameswaran N, Hall CS, Böck BC, Sparks HV, Gallo KA, Spielman WS. Mixed lineage kinase 3 inhibits platelet-derived growth factor-stimulated DNA synthesis and matrix mRNA expression in mesangial cells. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 12: 325-34. PMID 12438768 DOI: 10.1159/000067902  0.638
2000 Böck BC, Vacratsis PO, Qamirani E, Gallo KA. Cdc42-induced activation of the mixed-lineage kinase SPRK in vivo. Requirement of the Cdc42/Rac interactive binding motif and changes in phosphorylation. The Journal of Biological Chemistry. 275: 14231-41. PMID 10799501 DOI: 10.1074/Jbc.275.19.14231  0.65
Show low-probability matches.